title: Leukemia inhibitory factor enhances mast cell growth in a mast cell/fibroblast co-culture system through stat3 signaling pathway of fibroblasts.
abstract: Leukemia inhibitory factor (LIF) enhanced mast cell growth in a mast cell/3T3 fibroblast co-culture system, however the precise mechanisms have not been defined. Western blot analysis showed that bone marrow-derived mast cells failed to express both LIF receptor (LIFR) and gp130, whereas 3T3 fibroblasts expressed both LIFR and gp130. This result indicates that the activity of LIF for mast cell growth is mediated by 3T3 fibroblasts. Signal transducer and activator of transcription (Stat) 3-transfected 3T3 fibroblasts enhanced mast cell growth. In addition, dominant-negative Stat3-transfected fibroblasts blocked LIF-mediated mast cell growth in the co-culture system. In conclusion, LIF-induced mast cell growth in the co-culture system is mediated by an indirect pathway via 3T3 fibroblasts through activating Stat3 signaling pathway in 3T3 fibroblasts.
authors.affiliation: Department of Dermatology, Hiroshima University School of Medicine, Hiroshima, Japan. hiragun@hiroshima-u.ac.jp
authors.forename: T
authors.initials: T
authors.lastname: Hiragun
authors.forename: E
authors.initials: E
authors.lastname: Morita
authors.forename: S
authors.initials: S
authors.lastname: Mihara
authors.forename: T
authors.initials: T
authors.lastname: Tanaka
authors.forename: E
authors.initials: E
authors.lastname: Gyotoku
authors.forename: Y
authors.initials: Y
authors.lastname: Kameyoshi
authors.forename: S
authors.initials: S
authors.lastname: Yamamoto
mesh_terms: D016475:3T3 Cells; D000818:Animals; D015703:Antigens, CD / Q000502:physiology; D001854:Bone Marrow Cells; D002478:Cells, Cultured; D018920:Coculture Techniques; D050822:Cytokine Receptor gp130; D004268:DNA-Binding Proteins / Q000378:metabolism*; D005347:Fibroblasts / Q000502:physiology*; D006131:Growth Inhibitors / Q000494:pharmacology*; D015847:Interleukin-4 / Q000494:pharmacology; D015850:Interleukin-6; D053605:Leukemia Inhibitory Factor; D053680:Leukemia Inhibitory Factor Receptor alpha Subunit; D008222:Lymphokines / Q000494:pharmacology*; D008297:Male; D008407:Mast Cells / Q000166:cytology* / Q000187:drug effects / Q000502:physiology*; D008562:Membrane Glycoproteins / Q000502:physiology; D051379:Mice; D008815:Mice, Inbred Strains; D010766:Phosphorylation; D018121:Receptors, Cytokine / Q000502:physiology; D053606:Receptors, OSM-LIF; D011994:Recombinant Proteins / Q000378:metabolism / Q000494:pharmacology; D050796:STAT3 Transcription Factor; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology*; D015534:Trans-Activators / Q000378:metabolism*; D014162:Transfection
chemical_list: D015703:Antigens, CD; D004268:DNA-Binding Proteins; D006131:Growth Inhibitors; C494200:Il6st protein, mouse; D015850:Interleukin-6; D053605:Leukemia Inhibitory Factor; D053680:Leukemia Inhibitory Factor Receptor alpha Subunit; C507838:Lif protein, mouse; C507841:Lifr protein, mouse; D008222:Lymphokines; D008562:Membrane Glycoproteins; D018121:Receptors, Cytokine; D053606:Receptors, OSM-LIF; D011994:Recombinant Proteins; D050796:STAT3 Transcription Factor; C494087:Stat3 protein, mouse; D015534:Trans-Activators; D050822:Cytokine Receptor gp130; D015847:Interleukin-4